Friday Nov 27 | ASHP
Sibutramine May Increase Cardiovascular-Event Risk
Preliminary data from a placebo-controlled, 10,000-patient study suggest that the antiobesity drug sibutramine may increase patients' risk of cardiovascular adverse events, FDA announced on Friday.
Journal Watch - Medicine that Matters
FDA Investigating Possible Link Between Sibutramine and Cardiovascular Events
The FDA has issued an early communication regarding a possible increased risk for adverse cardiovascular events associated with sibutramine , a prescription drug used to manage obesity.
FDA Reviews Safety of Diet Drug Meridia
Nov. 23, 2009 -- A new study of the weight loss drug Meridia is in the hands of FDA regulators, who've released an early communication based on preliminary data: certain patients taking the drug may have a higher risk of heart attacks , strokes, and other serious cardiovascular problems.
Meridia Side Effects - FDA says weight loss drug sibutramine may cause heart attack and stroke
The U.S. Food and Drug Administration is conducting a review of the weight loss medication sibutramine, marketed in prescription form as Meridia, due to a recent study suggesting heart problems may be associated with the medication.
Meridia (sibutramine hydrochloride): Early Communication about an Ongoing Safety Review
FDA is reviewing preliminary data from a recent study suggesting that patients using sibutramine have a higher number of cardiovascular events than patients using a placebo.
Abbott's diet drug's risks have FDA's attention
"The analysis of these data is ongoing and FDA is making no conclusions about the preliminary findings at this time," the agency said in a statement.
Early Communication about an Ongoing Safety Review of Meridia
Early Communication about an Ongoing Safety Review ofA A Meridia This information reflects FDA's current analysis of available data concerning this drug.
GMP Herbal Products Inc. is recalling Pai You Guo, a weight loss dietary supplement, because it contains drug ingredients not declared on the label.
California Company Recalls Weight Loss Supplement
A California company has recalled a weight loss supplement because it contains two undeclared ingredients that pose a health risk.
Pai You Guo, Marketed as Dietary Supplement - Recall
GMP Herbal Products and FDA notified consumers and healthcare professionals of a recall of Pai You Guo, a weight loss dietary supplement, due to the presence of undeclared drug ingredients.
US Food and Drug Administration
GMP Herbal Products, Inc. Issues a Voluntary Nationwide Recall of a...
FOR IMMEDIATE RELEASE a ' November 12, 2009 a ' Westminster, CA a ' GMP Herbal Products, Inc.
Possible fibromyalgia treatment needs more research
DEAR DR. GOTT: I read your column every day and am writing to you because of your willingness to share information on remedies that have been reported successful by your readers.
Fibromyalgia treatment needs more research
Dear Dr. Gott: The recent article on the difficulty in treating fibromyalgia reinforces the urgency in making available sibutramine hydrochloride monohydrate to FM sufferers.
Brain Serotonin Transporter Occupancy by Oral Sibutramine Dosed to...
Brain Serotonin Transporter Occupancy by Oral Sibutramine Dosed to Steady State: A PET Study Using 11C-DASB in Healthy Humans 1Wolfson Molecular Imaging Centre, The University of Manchester, Manchester, UK 2Icon Development Solutions, Manchester, UK 3Manchester Academic Health Science Centre, Stopford Building, The University of Manchester, ...
Differential changes in serum uric acid concentrations in sibutramine ...
Recent technological developments in the sequence capture of cellular events through a light microscope can be combined to image multiple independent experiments automatically, with many advantages.
3 new prescription diet drugs may soon help obese
Pedestrians walk across the street near Times Square in New York. About two-thirds of American adults are overweight or obese, putting them at an increased risk for diabetes, hypertension, heart disease, osteoarthritis, stroke, gallbladder disease, sleep apnea, respiratory problems and even some cancers.
Differential changes in serum uric acid concentrations in sibutramine ...
Background and aims: Elevated levels of serum uric acid are associated with an increased risk of cardiovascular morbidity and mortality.
Malaysia's Drug Control Authority has banned the use of Senna Plus Capsule 400mg as it failed scheduled poison sibutramine detection, a local newspaper reported on Wednesday.
Public told not to use Senna Plus Capsule
PUTRAJAYA: The Health Ministry has advised the public against buying and using a traditional product named Senna Plus Capsule 400mg as its registration has been cancelled by the Drug Control Authority .
Weight Loss Prescriptions to Children Increased 15-Fold
The number of off-label prescriptions for weight loss drugs to children and adolescents has increased 15-fold over an eight year period in Kingdom, although most young people only take the drug for a short time and are unlikely to have seen any benefit, according to a study published online Sept.